Julie A. Cox
University of the Sunshine Coast(AU)
Publications by Year
Research Areas
Carcinogens and Genotoxicity Assessment, interferon and immune responses, Cell death mechanisms and regulation, Virus-based gene therapy research, CAR-T cell therapy research
Most-Cited Works
- → Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases(2017)466 cited
- → DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors(2016)269 cited
- → Characterization of GSK′963: a structurally distinct, potent and selective inhibitor of RIP1 kinase(2015)146 cited
- → Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis(2019)142 cited
- → Discovery of Small Molecule RIP1 Kinase Inhibitors for the Treatment of Pathologies Associated with Necroptosis(2013)135 cited
- → Evidence-based guideline summary: Evaluation, diagnosis, and management of congenital muscular dystrophy(2015)109 cited
- → A High-throughput Pharmacoviral Approach Identifies Novel Oncolytic Virus Sensitizers(2010)100 cited
- → Identification of a RIP1 Kinase Inhibitor Clinical Candidate (GSK3145095) for the Treatment of Pancreatic Cancer(2019)82 cited
- → Enhancement of Vaccinia Virus Based Oncolysis with Histone Deacetylase Inhibitors(2010)72 cited
- → Microtubule disruption synergizes with oncolytic virotherapy by inhibiting interferon translation and potentiating bystander killing(2015)68 cited